1 – 10 of 29
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Galectin-3 is upregulated in frontotemporal dementia patients with subtype specificity
(
- Contribution to journal › Article
-
Mark
Inflammatory bowel disease induces pathological α-synuclein aggregation in the human gut and brain
(
- Contribution to journal › Article
- 2023
-
Mark
Targeting galectin-3 to counteract spike-phase uncoupling of fast-spiking interneurons to gamma oscillations in Alzheimer’s disease
(
- Contribution to journal › Article
-
Mark
Galectin-3 shapes toxic alpha-synuclein strains in Parkinson’s disease
(
- Contribution to journal › Article
- 2022
-
Mark
Early-life stress elicits peripheral and brain immune activation differently in wild type and 5xFAD mice in a sex-specific manner
(
- Contribution to journal › Article
-
Mark
APOE in the bullseye of neurodegenerative diseases : impact of the APOE genotype in Alzheimer’s disease pathology and brain diseases
(
- Contribution to journal › Scientific review
-
Mark
Galectin-3, a rising star in modulating microglia activation under conditions of neurodegeneration
(
- Contribution to journal › Scientific review
-
Mark
Galectin-3 is elevated in CSF and is associated with Aβ deposits and tau aggregates in brain tissue in Alzheimer’s disease
2022) In Acta Neuropathologica(
- Contribution to journal › Article
- 2021
-
Mark
The human bone marrow harbors a CD45− CD11B+ cell progenitor permitting rapid microglia-like cell derivative approaches
(
- Contribution to journal › Article
-
Mark
Amyloid Structural Changes Studied by Infrared Microspectroscopy in Bigenic Cellular Models of Alzheimer’s Disease
(
- Contribution to journal › Article